A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...
Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...
Valentine’s Day represents a perfect opportunity to highlight news and updates from across biopharma that have hearts a | ...
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...
As Alnylam Pharmaceuticals approaches its highly anticipated March 23 FDA decision date for a potential expansion of Amvuttra ...
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
After two contentious Senate committee hearings on President Donald Trump’s nominee for HHS secretary, the votes are in: ...
Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...
Spanish CDMO Laboratorios Farmacéuticos Rovi, known simply as Rovi, is part of a parade of biopharma contractors struggling to keep their manufacturing businesses growing in a post-COVID world. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback